Clinical Trial Update: A Study of ProQuad™ in Healthy Children in Korea (V221-023) [Phase 3]

View source ↗

Summary

Phase 3 trial of ProQuad in healthy children in Korea was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: TERMINATED | Results posted: 2012-10-10